Study: Oral THC Safe and Effective for Treatment of Spasticity in Pediatric Patients

DUSSELDORF, GERMANY — The administration of oral, synthetic THC (dronabinol) is safe and effective for the treatment of refractory spasticity in pediatric patients, according to clinical data published online ahead of print in the European Journal of Pediatric Neurology.

Researchers from the University of Dusseldorf in Germany assessed the palliative treatment of dronabinol in 16 adolescent subjects with complex neurological conditions. Subjects received dosing twice daily and the median duration of treatment was 181 days.

Oral THC…